BRK-B vs CBNA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
CBNA presents a stark contrast between strong growth and weak operational health, evidenced by a weak Piotroski F-Score of 3/9. While the stock is fundamentally undervalued relative to its Graham Number ($41.86) and Intrinsic Value ($89.09), the technical trend is heavily bearish (10/100). Strong earnings growth (38.7% YoY) and a low P/E ratio of 11.62 provide a bullish value case, but the poor health score and negative insider sentiment suggest caution.
Compare Another Pair
Related Comparisons
BRK-B vs CBNA: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Chain Bridge Bancorp, Inc. (CBNA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.